MedPath

Sannuo Biological Sensor Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period

Not Applicable
Conditions
Diabetes Mellitus
Continuous Glucose Monitoring System
First Posted Date
2025-04-01
Last Posted Date
2025-05-21
Lead Sponsor
Sinocare
Target Recruit Count
70
Registration Number
NCT06904846
Locations
🇧🇪

UZA ANTWERP UZA Dienst Endocrinologie, Antwerp, Belgium

Effect of CGM on Glucose Control in Non-insulin-treated Patients with Type 2 Diabetes Mellitus

Not Applicable
Not yet recruiting
Conditions
Diabetes Mellitus
First Posted Date
2024-09-09
Last Posted Date
2024-09-09
Lead Sponsor
Sinocare
Target Recruit Count
160
Registration Number
NCT06587438

Continuous Glucose Monitoring System Use in Pediatric Patients With Diabetes

Recruiting
Conditions
Diabetes Mellitus
First Posted Date
2024-08-26
Last Posted Date
2024-08-26
Lead Sponsor
Sinocare
Target Recruit Count
78
Registration Number
NCT06570551
Locations
🇨🇳

Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China

🇨🇳

Hunan Children's Hospital, Changsha, Hunan, China

🇨🇳

Children's Hospital of Soochow University, Suzhou, Jiangsu, China

Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose Level Monitoring

Completed
Conditions
Type 1 or Type 2 Diabetes
First Posted Date
2023-08-16
Last Posted Date
2023-09-01
Lead Sponsor
Sinocare
Target Recruit Count
120
Registration Number
NCT05995756
Locations
🇨🇳

Beijing Pinggu Hospital, Beijing, China

🇨🇳

Peking University People's Hospital, Beijing, China

🇨🇳

The Second Xiangya Hospital of Central South University, Changsha, China

The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus

Completed
Conditions
T1DM - Type 1 Diabetes Mellitus
First Posted Date
2023-06-18
Last Posted Date
2024-12-03
Lead Sponsor
Sinocare
Target Recruit Count
134
Registration Number
NCT05908448
Locations
🇺🇸

Atlanta Diabetes Associates, Atlanta, Georgia, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath